• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPharmaceutical Industry

Pharmaceutical Industry

Page 81 of 100
Pershing Square's Bill Ackman and Valeant Pharmaceuticals International's Michael Pearson Interview
HealthBill Ackman Just Got Himself a Board Member on Valeant
By ReutersMarch 9, 2016
Pershing Square's Bill Ackman and Valeant Pharmaceuticals International's Michael Pearson Interview
FinanceHere’s Why Shares of Valeant Are Jumping Today
By ReutersMarch 7, 2016
Drugs From European Pharmaceuticals Companies As Stocks Outperformed The Stoxx 600 Index By 1.2 percentage Points
HealthEurope Launches New Fast-Track Scheme for Drug Approval
By ReutersMarch 7, 2016
Scientists Just Made a Major Breakthrough in Personalized Cancer Treatment
HealthScientists Just Made a Major Breakthrough in Personalized Cancer Treatment
By Sy MukherjeeMarch 4, 2016
Hillary Clinton Holds Post-Super Tuesday Rally In NYC
FinanceThis Is Why Hillary Clinton’s Attack on Drug Price Hikes Doesn’t Add Up
By Jen WiecznerMarch 4, 2016
97236087
HealthThe FDA Wants to Find Out if Cartoon Drug Ads Are Bad for Consumers
By Sy MukherjeeMarch 2, 2016
The Newly Refurbished Charles Dickens Museum Prepares To Open
HealthFemale Viagra Might Not Be All It’s Cracked Up To Be
By Robert HackettMarch 1, 2016
559537925
HealthWhy Shares of Diplomat Pharma Got Slammed Today
By Sy MukherjeeMarch 1, 2016
Roche's colon-cancer drug Avastin is displayed in a Cambridg
HealthThe US Throws Away $3 Billion Worth of Cancer Drugs A Year
By Laura LorenzettiMarch 1, 2016
Cancer research laboratory
HealthPharma’s Big New Cancer Drug May Be an Old Red Dye
By ReutersFebruary 26, 2016
Exclusive Look At Pharmaceuticals Manufacturing Inside Lupin Ltd. Facility, India's Third-Largest Drugmaker
FinanceIndian Companies Want to Sell U.S. Customers More Drugs
By Laura LorenzettiFebruary 25, 2016
An Initiative To Legalize Marijuana In California To Appear On Nov. Ballot
RetailCanada’s Biggest Drugstore Could Start Selling Medical Marijuana
By Tom Huddleston Jr.February 24, 2016
CVS - Most Admired 2016
HealthCVS Health Says Prescription Drug Spending Dropped Dramatically
By Laura LorenzettiFebruary 23, 2016
Senate Permanent Subcommittee On Investigations Hearing On U.S. Corporate Tax Code
FinanceHere’s Why Valeant Shares Are Plunging Again
By ReutersFebruary 23, 2016
The headquarters of Valeant Pharmaceuticals International, Inc. stands in Bridgewater Township, U.S., on Wednesday Nov. 04, 2015. Photographer: Michael Nagle/Bloomberg
FinanceHere’s Why Shares of Valeant Have Plunged for Their Second Straight Day
By ReutersFebruary 22, 2016
1...
  • 79
  • 80
  • 81
  • 82
  • 83
...100
Most Popular
AI
A Meta employee created a dashboard so coworkers can compete to be the company's No. 1 AI token user—and Zuckerberg doesn't even rank in the top 250placeholder alt text
By Fortune EditorsApril 9, 2026
Investing
Mark Cuban admits he made a mistake letting go of the Mavericks: 'I don't regret selling. I regret who I sold to'placeholder alt text
By Fortune EditorsApril 9, 2026
Economy
The U.S. government is spending $88 billion a month in interest on national debt—equal to spending on defense and education combinedplaceholder alt text
By Fortune EditorsApril 9, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.